• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Primary Cells Companies

    ID: MRFR/LS/4835-CR
    78 Pages
    Kinjoll Dey
    January 2020

    Primary cells are cells that are directly isolated from living organisms and have not been cultured or passaged in a laboratory setting. They are widely used in various fields of research, including cell biology, drug development, and regenerative medicine. Several companies specialize in providing primary cells and related products.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Primary Cells Market

    Primary Cells Key CompaniesDisclaimer: List of key companies in no particular orderLatest Primary cells Companies Update



    • Dec 2023: The premier supplier of clinical-grade (GMP-compliant) & Research Use Only (RUO) primary cell products, AllCells®, was acquired by Discovery Life SciencesTM, the biospecimen and biomarker expertsTM, today. AllCells and Discovery, with their combined thirty years of experience in cell and gene therapy (CGT), will concentrate on offering cutting-edge products and services that are more dependable and faster to meet the needs of the whole CGT continuum—from basic Discovery to commercialization. By fusing Discovery's biospecimen and biomarker knowledge with AllCells' established industry experience, the company becomes the go-to source for crucial starting materials and analytical services that speed up CGT applications. Discover will merge AllCells with its current CGT offerings to form a new business division called AllCells, a Discovery Life Sciences Business. One of the market's biggest dedicated customer donor pools is also created by the union of AllCells with Discovery's expanding CGT business. Characterization labs are next to GMP-compliant cleanrooms and donor collection facilities registered with the FDA.




    • June 2023: Type 1 diabetes affects 1.9 million persons in the United States. Patients who struggle to control the quantity of insulin required to avoid hypoglycemia episodes are among them. According to the FDA, people might also experience hypoglycemia unawareness, which is the inability to recognize when their blood sugar is falling. For these people, lantidra is an available therapy choice. A second dosage of lanthidra may be given to some patients based on how well they respond to the initial infusion, which is given into the liver portal vein. Two patients who underwent Vertex's stem cell treatment over a year ago reportedly no longer required injections.


    List of Primary cells Key companies in the market

    • AllCells (US)

    • ZenBio Inc. (Research Triangle Park, NC)

    • PromoCell (UK)

    • Thermo Fisher Scientific Inc. (US)

    • Cell Biologics Inc. (Chicago)

    • STEMCELL Technologies Inc. (Canada)

    • Merck KGaA (Germany)

    • American Type Culture Collection (ATCC)

    • AG (Switzerland)